Target intelligence / Profile preview

Immunoglobulin lambda variable 3-22 (IGLV3-22)

Target
IGLV3-22
Molecular classification
Immunoglobulin variable domain, Antibody variable region, Other
01

Overview

Immunoglobulin lambda variable 3-22 (IGLV3-22) is a gene encoding the variable region of the lambda light chain of human immunoglobulins (antibodies)[1][3]. The protein product is part of the variable domain of the antibody light chain, responsible for antigen binding specificity. It participates in the V(D)J recombination process during B cell development, enabling large diversity in antibody recognition. The primary biological role of IGLV3-22 is in the humoral immune response, where, as part of the immunoglobulin molecule, it binds foreign antigens and initiates immune effector functions. It resides in the variable region for lambda chains located at chromosome 22q11.2[3]. IGLV3-22 is not considered a direct therapeutic target (such as an enzyme, transporter, or receptor), but its products are essential components of natural immune function and may be indirectly involved in some diseases via immune dysregulation[1][3].

Other names
IGLV3-22IGLV322V2-15
02

Biological functions

Antigen recognitionImmune response
03

Disease associations

Other (associated with immune response and rare links to disease such as Autism Spectrum Disorder[1])

Beyond the preview

Go deeper on Immunoglobulin lambda variable 3-22 (IGLV3-22).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin lambda variable 3-22 (IGLV3-22).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call